SCHEMBL5659515

SCHEMBL5659515

C=CCOCc1cc2c(C(=O)OC)cc(OC)c(OC)c2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
POLB P06746 3/20 0.41
USP2 O75604 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
HSP90AA1 P07900 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
PTGS1 P23219 2/20 0.36
PTGS2 P35354 2/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA13 Q8N1Q1 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5659514 0.81 PTGS1 (0.37) KDM4EMAPTPTGS1PTGS2CA12
SCHEMBL5660900 0.81 CYP3A4 (0.35) KDM4EPOLBHSD17B10MAPTPTGS1
SCHEMBL5658621 0.80 KDM4E (0.49) KDM4EPOLBUSP2HSD17B10CA12
SCHEMBL5659291 0.80 MEN1 (0.41) KDM4EPOLBNPC1MAPTRAB9A
SCHEMBL5655596 0.79 KDM4E (0.48) KDM4EPOLBUSP2HSD17B10CA12
SCHEMBL5659653 0.77 PDE4A (0.50) KDM4EPOLBUSP2HSD17B10CA12
SCHEMBL5656372 0.75 KDM4E (0.44) KDM4EPOLBUSP2HSD17B10SMN1; SMN2
SCHEMBL5657720 0.74 KDM4E (0.46) KDM4EPOLBUSP2HSD17B10SMN1; SMN2
SCHEMBL5657121 0.74 MEN1 (0.43) KDM4EPOLBUSP2HSD17B10ALDH1A1
SCHEMBL5669321 0.73 KDM4E (0.49) KDM4EPOLBUSP2HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR KDM4E 1540/4885POLB 731/4885USP2 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.